LD

Liz Dallimore

Argenica Therapeutics Limited | Chief Executive Officer, Managing Director
Dr Dallimore is a research & development, innovation and commercialsation specialist with over 20 years' experience across Australia and the UK. Prior to joining Argenica Therapeutics, Dr Dallimore was the Director of the WA Data Science Innovation Hub, tasked with working across WA businesses to establish data science projects. Dr Dallimore has also held senior roles in management consulting across Australia, most recently as KPMG's National Director of Research Engagement and Commercialisation. Prior to this she held senior roles with Ernst & Young and PricewaterhouseCoopers. Dr Dallimore is a co-founder and non-executive Chair of medical device company Inspiring Holdings, a non-executive Director of AusBiotech and a non-executive Director of the Chamber of Commerce and Industry, WA. Dr Dallimore has worked as a neuroscientist at the Australian Neuromuscular Research Institute (now Perron Institute).

Company and Roles

Company
Title
Tenure
Since
AGN
Argenica Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
4yrs, 3mthApr 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AGN
Argenica Therapeutics Limited
30/06/25N/A1,993,254N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AGN
Argenica Therapeutics Limited
03/06/25
Issued
352,345$0.770$271,305Exercise of options
AGN
Argenica Therapeutics Limited
03/06/25
Cancelled
1,647,655$0.770$1,268,694Cancellation of securities
AGN
Argenica Therapeutics Limited
03/06/25
Exercise
352,345$0.770$271,305Exercise of options
AGN
Argenica Therapeutics Limited
08/08/24
Buy
1,590,909$0.790$1,256,818Exercise of options
AGN
Argenica Therapeutics Limited
08/08/24
Exercise
1,590,909$0.790$1,256,818Exercise of options